Abstract: The present invention provides antibodies that bind to human GFR?3 and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human GFR?3. The antibodies of the invention are useful for the treatment of diseases and disorders associated with one or more GFR?3 biological activities, including the treatment of acute or chronic pain conditions, or inflammatory conditions.

Abstract: The invention relates generally to variant activatable antibodies that include a masking moiety (MM), a cleavable moiety (CM), and an antibody (AB) that specifically binds to epidermal growth factor receptor (EGFR), and to methods of making and using these variant anti-EGFR activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Abstract: The present invention relates to amino acid sequences that are directed against RANK-L, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The invention also relates to nucleic acids encoding such amino acid sequences and polypeptides; to methods for preparing such amino acid sequences and polypeptides; to host cells expressing or capable of expressing such amino acid sequences or polypeptides; to compositions, and in particular to pharmaceutical compositions, that comprise such amino acid sequences, polypeptides, nucleic acids and/or host cells; and to uses of such amino acid sequences or polypeptides, nucleic acids, host cells and/or compositions, in particular for prophylactic, therapeutic or diagnostic purposes.

Abstract: A fully human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits human TNF-like ligand 1A (hTL1A) is provided. The human anti-hTL1A antibodies are useful in treating diseases or disorders associated with TL1A, such as inflammatory diseases or disorders, e.g., inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, rheumatoid arthritis, and the like; autoimmune diseases or disorders, such as multiple sclerosis, diabetes, and the like; and allergic reactions, such as asthma and allergic lung inflammation.

Abstract: Provided herein are compositions comprising anti-IGF-1R, anti-ErbB3 bispecific antibodies alone or in combination with other anti-cancer agents. Also provided are methods of treating a subject having cancer and methods for determining whether a patient with cancer is likely to respond to the compositions described herein.

Abstract: The present invention provides an anti-human Notch4 antibody or a Notch4 binding fragment thereof that may have neutralizing activity against human Notch4, as well as a pharmaceutical composition comprising the same as the active ingredient. The present inventors obtained a mouse anti-human Notch4 antibody that has high neutralizing activity and binding affinity towards human Notch4 and determined the complementarity determining region (CDR) sequence of said mouse anti-human Notch4 antibody. This enabled the production of a humanized antibody comprising the variable region of heavy and light chains as well as the CDR sequence of said mouse anti-human Notch4 antibody.

Abstract: Isolated polypeptides comprising or consisting essentially of specific structural motifs (e.g., three ?-sheets and two ?-helices) are provided, wherein the polypeptides exhibit at least one cell signaling and/or other non-canonical activity of biological relevance. Also provided are polynucleotides encoding such polypeptides, binding agents that bind such polypeptides, analogs, variants and fragments of such polypeptides, etc., as well as compositions and methods of identifying and using any of the foregoing.

Abstract: The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.

Abstract: An human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits human proprotein convertase subtilisin/kexin type 9 (hPCSK9) characterized by the ability to reduce serum LDL cholesterol by 40-80% over a 24, 60 or 90 day period relative to predose levels, with little or no reduction in serum HDL cholesterol and/or with little or no measurable effect on liver function, as determined by ALT and AST measurements.

Abstract: Provided herein are methods for inducing growth arrest or apoptosis in cancer cells in a subject. Further provided are methods of inhibiting or treating metastasis of a cancer cell in a subject. The methods involve administering to the subject an antibody conjugate containing an antibody, variant thereof, or functional fragment thereof having binding specificity of the antibody as produced by the hybridoma having ATCC accession number PTA 2439 and a biologically active molecule. The antibody (e.g., mAb 3E10) variant or functional fragment thereof provides for the in vivo transduction of the conjugate to the nucleus of mammalian cells, where the conjugated biologically active molecule may exert its effect. In particular embodiments, the antibody conjugate comprises a single chain Fv fragment of an antibody having the binding specificity of mAb 3E10 produced by ATCC PTA 2439, conjugated to p53.

Abstract: The invention discloses methods for the generation of chimaeric human—non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods.

Abstract: The present invention describes a process for the acetylation of wood comprising treating wood with an acetylation agent comprising acetic anhydride and/or acetic acid and subjecting to acetylation conditions, wherein the acetylation reaction is carried out in the presence of an acetylation catalyst comprising a salt of an organic acid, wherein the organic acid is a carboxylic acid, phenol or a substituted phenol, wherein the carboxylic acid is chosen from the list consisting of aromatic carboxylic acids, medium chain saturated monocarboxylic acids, keto acids, dicarboxylic acids, tricarboxylic acids, hydroxy acids, amino acids and derivatives thereof.

Abstract: The present invention relates to site-selective modification of polysaccharides at their reducing end by conjugation with a single aminoxy-Regioselective Addressable Functionalized Template (RAFT) peptide.

Abstract: A method for producing a hydrogenated petroleum resin by reacting dicyclopentadiene with a vinyl aromatic compound, subjecting the reaction product obtained by this reaction to thermal polymerization, and then hydrogenating the resulting product, including the following steps (A) to (C): (A) a preliminary reaction step of reacting a vinyl aromatic compound represented by the following Formula (1) (in the formula, R1 is a hydrogen atom or the like) with dicyclopentadiene under the condition that selectivity for a phenylnorbornene derivative, which is a reaction product and is represented by the following Formula (2) {in the formula, R1 has the same meaning as in the above Formula (1)}, is 90% or more to obtain a reaction liquid containing the phenylnorbornene derivative: (B) a polymerization step of heating the reaction liquid, which contains the phenylnorbornene derivative and is obtained in the preliminary reaction step (A), to a temperature of 240 to 300° C.

Abstract: Provided herein are methods for preparing a functionalized polyolefin from an unsaturated polyolefin containing one or more non-aromatic main-chain double bonds and for reducing the size and/or polydispersity index (i.e., increasing the homogeneity) of the unsaturated polyolefin.

Abstract: Solid catalyst components for use in olefin polymerization, olefin polymerization catalyst systems containing the solid catalyst components, methods of making the solid catalyst components and the catalyst systems, and methods of polymerizing and copolymerizing olefins involving the use of the catalyst systems. The solid catalyst components are formed by (a) dissolving a magnesium compound and an auxiliary intermediate electron donor in at least one first solvent to form a solution; (b) contacting a first titanium compound with said solution to form a precipitate of the magnesium compound and the first titanium compound; (c) washing the precipitate with a mixture of a second titanium compound and at least one second solvent and optionally an electron donor at a temperature of up to 90° C.; and (d) treating the precipitate with a mixture of a third titanium compound and at least one third solvent at 90-150° C. to form a solid catalyst component.

Abstract: The present invention provides a method for producing a fluoropolymer aqueous dispersion having a significantly small particle size and excellent dispersion stability. The present invention relates to a method for producing an aqueous dispersion containing at least one fluoropolymer selected from the group consisting of polytetrafluoroethylene and melt-fabricable fluororesins excluding polytetrafluoroethylene. The method includes polymerizing a fluoromonomer in an aqueous medium in the presence of a fluorosurfactant and a polymerization initiator. The fluorosurfactant has a concentration in the aqueous medium of not lower than 0.8 times the critical micelle concentration of the fluorosurfactant.

Abstract: An acrylic acid-based polymer composition of the present invention is obtained using a hypophosphorous acid compound in an amount of 0.5 to 4.5 parts by mass based on 100 parts by mass of a total of monomers for forming structural units of the acrylic acid-based polymer and adding 1% to 500 by mass of a total amount of the hypophosphorous acid compound to a reactor before supplying the monomer. The phosphorous acid ion is contained in an amount of 20 to 1,000 ppm by mass based on a solid content of the acrylic acid-based polymer.

Abstract: A catalyst system including the reaction product of a fluorided support (such as a fluorided silica support) that preferably has not been calcined at a temperature of 400° C. or more, an activator and at least a first transition metal catalyst compound; methods of making such catalyst systems, polymerization processes using such catalyst systems and polymers made therefrom.

Abstract: Catalyst compounds and catalyst systems including an asymmetric Salan ligands having a fluorenyl moiety are disclosed. Methods of preparing such catalyst compounds and catalyst systems, polymerization processes using such catalysts systems and olefin polymers prepared according to such processes using the catalysts systems are described.

Abstract: A catalyst system including the reaction product of a fluorided support, an activator, and at least a first transition metal catalyst compound; methods of making such catalyst systems, polymerization processes using such catalyst systems, and polymers made therefrom.

Abstract: This invention relates to a process to polymerize olefins comprising: i) contacting one or more olefins with a catalyst system comprising: 1) a support comprising an organoaluminum treated layered silicate and an inorganic oxide; and 2) a bisphenolate compound; and ii) obtaining olefin polymer having high molecular weight and layered silicate dispersed therein. Preferably the support is in the form of spheroidal particles.

Abstract: A catalyst system including the reaction product of a fluorided support, an activator, and at least a first transition metal catalyst compound; methods of making such catalyst systems, polymerization processes using such catalyst systems, and polymers made therefrom.

Abstract: This invention relates to a process to polymerize olefins comprising: i) contacting one or more olefins with a catalyst system comprising: 1) a support comprising an organoaluminum treated layered silicate and an inorganic oxide; and 2) a bisphenolate compound; and ii) obtaining olefin polymer having high molecular weight and layered silicate dispersed therein. Preferably the support is in the form of spheroidal particles.

Abstract: Disclosed herein are ethylene-based polymers having a density greater than 0.945 g/cm3, a high load melt index less than 25 g/10 min, a peak molecular weight ranging from 52,000 to 132,000 g/mol, and an environmental stress crack resistance of at least 250 hours. These polymers have the processability of chromium-based resins, but with improved impact strength and stress crack resistance, and can be used in large-part blow molding applications.

Abstract: Provided is a copolymer comprising from about 88 to about 92 mol % of a hydrophilic unit derived from N-vinylpyrrolidone and a cationic unit derived from a dimethyldiallylammonium salt, wherein the copolymer has a molar mass greater than or equal to 250,000 g/mol. Said copolymer is useful especially as a suds boosting polymer in hand dishwashing detergent compositions comprising a surfactant system, and provides improved foaming properties.

Abstract: The present invention provides an olefin resin (?) satisfying the following requirements (I) to (VI), and a propylene resin composition including the same. (I) (?) includes a grafted olefin polymer [R1] containing a main chain composed of an ethylene/?-olefin copolymer and a side chain composed of a propylene polymer. (II) The ratio P wt % of the amount of the propylene polymer contained in (?) is from 5 to 60 wt %. (III) When the ratio of the amount of a component(s) having a peak temperature of a differential elution curve as measured by cross-fractionation chromatography (CFC) using o-dichlorobenzene as a solvent of less than 65° C., to the amount of (?) is taken as E wt %, the value a represented by the following equation (Eq-1), in relation to the ratio E and the ratio P, is 1.4 or more. (IV) The melting point (Tm) and the glass transition temperature (Tg), as measured by differential scanning calorimetry (DSC), are from 120 to 165° C. and from ?80 to ?30° C., respectively.

Abstract: The object of the present invention is to provide a resin particle having a protrusion that is more resistant to the detachment and having a uniform protrusion size and protrusion distribution density. The resin particle of the present invention comprises: a spherical part and a peripheral part having a plurality of convex part formed on the surface of the spherical part, wherein the spherical part and the peripheral part comprise a vinyl polymer and/or a polysiloxane component, the spherical part and the peripheral part are different in the composition, the melting point of the peripheral part is not less than 200° C., and the curvature center of the boundary between the peripheral part and the spherical part determined by a transmission electron microscope observation of the cross-section of the resin particle exists in the spherical part.

Abstract: The present invention relates to a process for preparing a polymer with a mass Mw of less than 300 000 g/mol (especially between 1000 and 300 000 g/mol), comprising a step (E) of controlled radical polymerization in which the following are placed in contact in an aqueous medium in which are dispersed surfactant micelles: ethylenically unsaturated hydrophilic monomers predominantly present in the aqueous medium; partially water-soluble ethylenically unsaturated hydrophobic monomers different from the preceding monomers, at least partly present in the surfactant micelles, and having a solubility in the aqueous medium at least equal to that of hexyl acrylate; at least one radical polymerization initiator; and at least one radical polymerization control agent.

Abstract: Described herein are copolymers, and methods of making and utilizing such copolymers. Such copolymers have at least two blocks: a first block that has at least one unit that is hydrophilic at physiologic pH, and a second block that has hydrophobic groups. This second block further has at least one unit with a group that is anionic at about physiologic pH. The described copolymers are disruptive of a cellular membrane, including an extracellular membrane, an intracellular membrane, a vesicle, an organelle, an endosome, a liposome, or a red blood cell. Preferably, in certain instances, the copolymer disrupts the membrane and enters the intracellular environment. In specific examples, the copolymer is endosomolytic.

Abstract: A novel formulation for preparing a polyurethane foam with low density, desirable hardness, good appearance, and good adhesion to a polymer film without compromising the processing properties of the formulation; and a process for preparing a multilayer structure made of the polyurethane foam.

Abstract: A composition comprising: lignin, a polyol carrier compound and an isocyanate is disclosed. The lignin being mixed with the polyol carrier compound. The polyol carrier compound is selected from the group consisting of TCPP, TECP, TMCP, TDCP, etholoxylated and propoxylated phenols, tris-chloroisopropyl phosphate, amino methyl propanol , glycerin carbonate, polyether modified polysiloxanes, bromophthalic anhydride derivatives, propanediols; bromine, chlorine and/or phosphorus based fire retardents, epoxies, glycerins, sugar, glycols, certain natural oil based polyols and ethoxylated and or propoxylated alcohols. The lignin-polyol carrier compound mixture is reacted with the isocyanate producing a foam, plastic or other material. For a thermoplastic solid the same polyol carrier compounds are used but in higher percentages of lignin.

Abstract: A method for preparing an amphoteric shape-memory polyurethane and an amphoteric shape-memory polyurethane prepared by the method, the method including:1) polymerizing monomer A and monomer B to synthesize a polyurethane; and 2) contacting monomer D and the polyurethane to conduct a ring-opening reaction on a nitrogen group of the polyurethane, to yield an amphoteric shape-memory polyurethane. The monomer A is a N-alkyl dialkanolamine having a formula I. The monomer B is a polyisocyanate, and the monomer D is an alkyl sulfonate.

Abstract: This invention provides a polymer, which is preferably a polyether polymer. The polymer may be uses in coating compositions. Containers and other articles comprising the polymer and methods of making such containers and other articles are also provided. The invention further provides compositions including the polymer (e.g., powder coatings), which have utility in a variety of coating end uses, including, for example, valve and pipe coatings.

Abstract: The present invention relates to an epoxy resin composition containing an alicyclic epoxy compound (A), a polymer polyol having two or more terminal hydroxyl groups (B), and a Lewis acid-amine complex (C). The present invention provides an epoxy resin composition which can be cured by heating at low temperatures, and suppresses heat generation associated with curing (heat generation by curing). It is preferable that the epoxy resin composition further contains an antioxidant. Furthermore, it is preferable that the antioxidant is a phosphite ester compound.

Abstract: The present teachings relate to new semiconducting polymers including an optionally substituted naphtho[1,2-d:5,6-d]bis[1,2,3]thiadiazole moiety, an optionally substituted naphtho[2,1-d:6,5-d]bis[1,2,3]thiadiazole moiety, or a chalcogen analog thereof. The present polymers can be used to prepare thin film semiconductor components which can be incorporated into various electronic, optical, and optoelectronic devices.

Abstract: A polymer and a method for its preparation are provided. The polymer comprises poly(lactide), poly(lactide/glycolide) or poly(lactic acid/glycolic acid) segments bonded by ester linkages to both ends of an alkanediol core unit. The polymer is for use in a controlled release formulation for a medicament, preferably leuprolide acetate. The controlled release formulation is administered to a patient as a subcutaneous depot of a flowable composition comprising the polymer, a biocompatible solvent, and the medicament. Controlled release formulations comprising the polymer release leuprolide for treatment of prostate cancer patients over periods of 3-6 months.

Abstract: The present invention is related to the application of solid polymers or copolymers prepared from monomers having in their structure a polycyclic aromatic ring, an aromatic ring of the type of naphthalene, or polyesters, polyethers, polyamides or polyvynil derivatives having naphthalene units in their structure, in the hydrotreatment or hydrocracking of heavy hydrocarbons, such as heavy or extra-heavy crude oils or residues from the distillation of petroleum; these polymers or copolymers may be supported, anchored or in a physical mixture with metallic oxides such as alumina, silica, titania or kaolin, and they have an application as heterogeneous hydrogen donors in reactions of hydrotreatment or hydrocracking of heavy or extra-heavy crude oils, residues from the distillation of petroleum and cuts and streams deived from this distillation. These solid polymers or copolymers operate in the presence of hydrogen or methane-rich gas.

Abstract: The invention relates to a process for producing polyoxymethylene block copolymers, comprising the step of activating the DMC catalyst in the presence of an OH-terminated polymeric formaldehyde starter compound by means of a defined amount of alkylene oxide, optionally followed by polymerization with alkylene oxides, if necessary in the presence of other comonomers. The invention further relates to polyoxymethylene block copolymers that can be obtained by means of such a process and to the use of these for producing polyurethane polymers.

Abstract: Provided is an alkylene oxide polymer production method, whereby it becomes possible to produce an alkylene oxide polymer having a high polymerization degree on an industrial scale and with high reproducibility. An alkylene oxide polymer production method comprising carrying out a polymerization reaction of an alkylene oxide in an inert hydrocarbon solvent in the presence of a zinc catalyst to produce an alkylene oxide polymer, wherein the zinc catalyst is produced by reacting an organozinc compound with a monohydric alcohol in an amount of 12-fold equivalent or less relative to the amount of the organozinc compound and an aliphatic polyhydric alcohol in an amount of 0.2- to 1.1-fold equivalent relative to the amount of the organozinc compound, and the polymerization reaction is carried out under such a condition that the amount of the monohydric alcohol in the polymerization reaction system becomes 0.01-fold equivalent or less relative to the amount of the organozinc compound.

Abstract: A composition for preparing a hybrid resin includes: a polymer including a repeating unit derived from allyl glycidyl ether; a thiol-based compound; and a photoinitiator, wherein the thiol-based compound is selected from a first thiol-based compound including a silyl group, a second thiol-based compound including a moiety derived from a photochromic compound, and a combination thereof. A hybrid resin, and a hybrid resin film prepared from the composition are also disclosed.

Abstract: Composition comprising, on a weight basis, the total being equal to 100%: from 98% to 100% of at least one copolyamide bearing amide units and polyether units, having a melting point (Tm) from about 90 to about 150° C., in particular from about 100° C. to about 125° C., and having a flexural modulus of less than 100 MPa, as determined according to standard ISO 178 (2010); from 0 to 2% of at least one additive chosen from stabilizers and dyes, or a mixture thereof, for the manufacture of a heat-sensitive adhesive, in particular a veil, a film, granules, a filament, a grate, a powder or a suspension.

Abstract: Disclosed is a polyimide precursor composition for the production of a flexible board of a photoelectronic device. The polyimide precursor composition includes a polyimide precursor derived from a diamine or acid dianhydride including a structure of Formula 1: wherein R1 to R8, m1, m2, and m3 are as defined in the specification. Also disclosed is a polyimide film produced from the polyimide precursor composition. The polyimide film is obtained by applying the precursor composition to a substrate and curing the composition. The polyimide film has high transparency and good heat resistance. In addition, the polyimide film exhibits good dimensional stability because the substrate does not undergo an increase in stress even during high-temperature heat treatment.

Abstract: In some cases, fabricating a high refractive index polymer composite may include combining a thiol monomer and an ene monomer to yield a composite mixture, heating the composite mixture to yield a homogenous composite mixture, and curing the homogeneous composite mixture to yield a polymer composite, wherein the ene monomer comprises zirconium oxo (meth)acrylate clusters. The refractive index of the high refractive index polymer composite may be at least 1.70. In certain cases, fabricating a high reactive index polymer composite includes combining a vinyl (ene) monomer, a thiol monomer, and zirconium oxo (meth)acrylate clusters to yield a composite mixture, heating the composite mixture to yield a homogenous composite mixture, and curing the homogeneous composite mixture to yield a polymer composite. The refractive index of the high refractive index polymer composite may be at least 1.75.

Abstract: The disclosure describes new compositions and methods related to polyaminals and related polymers. The compositions are useful as therapeutic/drug conjugates, self-healing materials, reversible crosslinking materials, degradable hydrogels, protective coatings, and as metal scavenging agents. New atom efficient synthetic schemes are disclosed, which yield previously unobtainable high molecular weight polyaminals.

Abstract: An aminosiloxane polymer includes at least one Si-bonded functional group. This functional group has the chemical formula: —(R—NH)aR1—N(R2)—CH(—COOH)(—R3—C(?O)—NR42) (I). In Formula (I), R is a C1-C10 hydrocarbon group. R1 is a C1-C10 hydrocarbon group. R2 is a hydrogen atom, a C1-C12 hydrocarbon group, or a phenyl group. R3 is a C1-C4 hydrocarbon group. Each R4 is independently a hydrogen atom, a C1-C12 hydrocarbon group, a C1-C12 hydroxyl-hydrocarbon group, or a phenyl group. Moreover, “a” is 0 or 1, such that (R—NH) is optional. The aminosiloxane polymer can be formed using the method of this disclosure and can be formed in, and/or included in, the emulsion of this disclosure.

Abstract: A cross-linked aminosiloxane polymer includes a first siloxane backbone, a second siloxane backbone, and at least one intramolecular structure cross-linking a silicon atom of the first siloxane backbone and a silicon atom of the second siloxane backbone. The intramolecular structure has the chemical structure: (I) In Formula (I), X is chosen from the following groups; (II); (III); or (IV). In groups (II), (III), and (IV), each R is independently a C1-C10 hydrocarbon group. Each R1 is independently a C1-C10 hydrocarbon group. Each R2 is independently a hydrogen atom, OH, a C1-C12 hydrocarbon group, a phenyl group, R?(OR?)m, or R?OH. Each of R? and R? is independently an alkyl group and “m” is 1 to 3. Moreover, “a” is 0 or 1. The cross-linked aminosiloxane polymer can be formed by the method of this disclosure.

Abstract: According to an embodiment, natural polymers will be used to enhance the biodegradability of nanocomposites, increase potential use of sustainable polymer matrices, improve the interlaminar fracture toughness of graphite/epoxy composites and attain complete nanoparticle dispersion through covalent bonding of nanoparticles and natural polymers. The starch derivatives containing POSS (polyhedral silsesquioxane) were synthesized by reacting natural polymer with different POSS molecules in a solvent in presence of a catalyst. Interlaminar fracture toughness testing results from the epoxy based nanocomposites containing 3, 5, 7, and 10 wt % POSS modified natural polymer in the interlaminar area are presented. The biodegradability of the composites is expected to improve through the incorporation of the natural polymer derivatives.

Abstract: Disclosed is a film containing a copolyester having a minimum crystallization half-time of at least 8.6 minutes and a polyester plasticizer having a weight-average molecular weight of 900 to 12,000 g/mol. The polyester plasticizer includes (i) a polyol component comprising residues of a polyol having 2 to 8 carbon atoms, and (ii) a diacid component comprising residues of a dicarboxylic acid having 4 to 12 carbon atoms.

Abstract: A method of forming carbon-carbon composites includes molding carbon fibers with a compound comprising a blend of benzoxazine resin and cyanate ester resin; and pyrolyzing the compound to form the carbon-carbon composite. A carbon-carbon composite includes carbon fibers impregnated with a compound comprising a blend of benzoxazine resin and cyanate ester.